In Demon Slayer: Kimetsu no Yaiba, Tanjiro Kamado distinguishes himself through his compassion amidst a demon-ridden world. Unlike typical action heroes, Tanjiro's strength stems from his empathy ...

‘Tis the week for small AI models, it seems. Nonprofit AI research institute Ai2 on Thursday released Olmo 2 1B, a 1-billion-parameter model that Ai2 claims beats similarly-sized models from ...

The internet has found a new visual obsession, and it’s adorably small — Chibi-style photos. Riding on the heels of the Studio Ghibli-inspired AI trend, Chibi figures are now taking over ...

The internet is currently swept up in the Chibi craze, where users are transforming their photos into adorable, 3D-style Chibi figures reminiscent of Japanese gashapon toys. These miniature, anime ...

Zachary Evens: Small stocks have underperformed their larger counterparts for a long time, prompting some people, including myself, to ask: why bother with small-cap ETFs? While there’s an ...

(Photo by Chris Hondros/Getty Images) In the investment world, small caps are often an afterthought compared to large-cap and tech-related stocks, even as they quietly fly under the radar.

Demon Slayer explores the amazing growth of its main character, Tanjiro Kamado, from a fragile demon slayer to one of the most potent characters in the series, setting battles that are beyond ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

and it allows Tanjiro to get a small and much needed win. He wasn’t able to completely fight back against him in the first season after the Hashira attacked Nezuko, so attacking the Hashira’s ...

The Demon Slayer series has touched many pe­ople worldwide. It follows Tanjiro Kamado on his journey afte­r a tragic event. His family was brutally killed by de­mons, and his sister Nezuko was ...

In this piece, we will take a look at the 11 best small cap pharma stocks to invest in. If you want to skip our overview of the global pharmaceutical and healthcare industry, which is one the most ...